Unbound MEDLINE

Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin. The Israel Medical Association journal : IMAJ [Isr Med Assoc J] Journal article

 
TitleClinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
Author(s)Shapiro M, Cohen J, Inbal A, Singer P 
InstitutionDepartment of General Intensive Care, Rabin Medical Center, Beilinson Campus, Petah Tikvah and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. moriss@clalit.org.il
SourceIsr Med Assoc J 2009 Mar; 11(3):188-90.
Languageeng
Pub Type(s)Journal Article
PubMed ID19544713
  
Advertise on this site.